Biotechnology Licensing Benefits Both Commercial and Research Organizations

Biotechnology is an area of study that essentially deals with development of newer and innovative technologies based on genetics and medical research. Today, with almost all governments having an interest in the development of their biotechnology sectors to improve public health, there has been tremendous increase in the investment made by both public and private institutions in the industry. Biotechnology researchers are highly skilled professionals and they carry out intensive research to develop new products or technology that would improve the quality of the life of the general public. The products developed by biomedical research can be used in more than one field including the pharmaceutical industry, agricultural fields, protection and prevention of environmental deterioration and food and therapeutics.

Owing to the application of the biomedical research products in diverse fields, this research sector attracts a lot of investment from various commercial organizations. The businesses invest in the biotechnology field and develop a strategic partnership with biotechnology and research institution and obtain a commercialization of biomedical research license.

The partnership between the biomedical research institution and the commercial organization is beneficial for both parties involved in the collaboration. The commercial organizations get the technology to be used for making finished products that can be sold in the market for generate revenue, and the research institution obtains royalties for the sale of the finished product, which are utilized to help fund more research. Apart from the financial interest, the research organizations benefit in other ways by entering into diagnostic patent licensing agreements. While the research institutions develop new technologies or products that can be applied in the diverse fields, they may not have the essential resources or the capacity to exploit the fullest potential of the technology outside the core area for which it was developed. Also, the research institutions do not necessarily have the organizational capacity to convert the technology into a tangible product that can be marketed.

To establish a contract with the commercial organization, the research institutions work in association with company that specialize in offering technology transfer service, these companies have a wide network of industrial partners and they help the research institutions find investors in their technology. The technology transfer service providers work to protect the interest of the research organization - their services include find the right investors, helping the investors realize the commercial potential of the technology developed, negotiating the technology transfer terms and securing the intellectual property of the researchers by obtaining therapeutics patent licensing. The technology transfer service providers assist in safe transmission of the technology information, as well as overlook the interest of the business in obtaining the technology transfer licensing and ensure the deal is completed in accordance with the technology transfer rules of the federal government.

Comments? Questions? Email Here

© HowtoAdvice.com